CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Zhao ZA, Jiang Y, Chen YY, Wu T, Lan QS, Li YM, Li L, Yang Y, Lin CT, Cao Y, Zhou PZ, Guo JY, Tian YX, Pang JX.
Zhao ZA, et al. Among authors: li ym, li l.
Acta Pharmacol Sin. 2022 Jan;43(1):121-132. doi: 10.1038/s41401-021-00640-5. Epub 2021 Mar 25.
Acta Pharmacol Sin. 2022.
PMID: 33767379
Free PMC article.